TD Cowen raises Marex Group stock price target to $66 on investor day outlook

TD Cowen raised its price target on Marex Group to $66 from $61 and reiterated a Buy rating after the March 26 investor day; the firm also raised estimates and cited improved confidence in long-term growth and margin targets. Marex beat Q4 expectations with adjusted EPS $1.13 vs $0.99 consensus and revenue $572.1M vs $508.62M (up 38% YoY), driven by Prime Services; the stock trades at a P/E of 10.07 and PEG of 0.23. Shares have rallied ~14.66% over the past week, digital operations are expected to be ~7% of 2025 revenues, but InvestingPro flags the share price as above its Fair Value estimate.

Analysis

Investor-day driven re-ratings in capital-markets service providers rarely come from slides alone; the lever is durable mix-shift into higher-margin, recurring flows and the fixed-cost absorption that follows. If Marex can push a 5–10 percentage-point shift of revenue toward electronic/digital and prime services over 12–24 months, a 100–250bps operating-margin expansion is realistic via lower per-trade costs and higher annuity-like fee capture, which would force a re-rate even if top-line growth moderates.

Second-order winners include niche clearing and post-trade vendors that scale with Marex (custody, low-latency connectivity) and counterparties that benefit from larger, more concentrated netting relationships; conversely, smaller regional brokers and mid-tier liquidity providers face contraction pressure as platform consolidation accelerates. The key macro/market risk is volume/volatility normalization: a multi-quarter drop in derivatives activity or a liquidity shock that stresses intraday financing would compress revenue far faster than slide-deck optimism anticipates, so execution and credit-friction monitoring are pivotal in the next 3–9 months.

Near-term sentiment has likely priced a portion of the story, so trade framing should prioritize asymmetric payoffs that capture continued multiple expansion while protecting against execution setbacks. Watch next 2–3 quarters for measurable KPIs (net new prime mandates, recurring digital ARR, client retention rates) — those are the binary catalysts that convert narrative into sustainable cash flow and justify higher peer multiples.

Key Decisions for Investors

• Long MRX equity (6–12 month horizon): allocate 3–5% of portfolio on a staged basis (buy into 2–3 tranches on any 5–10% pullbacks). Target +30–50% total return if KPIs show durable mix shift; hard stop at 12% downside per tranche to limit execution risk.
• Buy MRX 9–15 month call debit spread to cap downside while keeping upside optionality: size to risk no more than 2% of portfolio. Reward scenario: 3x+ payoff if market grants a multiple expansion on sustained margin improvements; loss limited to premium paid if story disappoints.
• Pair trade (6–12 months): long MRX / short ICE (equal notional exposure) to isolate Marex-specific execution versus broad market-structure moves. Objective is relative outperformance of 20–30% if Marex gains share; tail risk if systemic clearing volumes rise (both legs appreciate).
• If holding MRX into near-term earnings or investor updates, sell 30–60 day covered calls (~30–40% OTM) to monetize elevated sentiment while retaining upside; roll if calls approach the money after positive catalysts. This harvests premium and reduces downside exposure in the event the market re-prices disappointment.